A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer

Clin Lung Cancer. 2006 Jan;7(4):285-7. doi: 10.3816/CLC.2006.n.009.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Cetuximab
  • Combined Modality Therapy
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / therapy*
  • Neoplasm Staging
  • Pemetrexed

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glutamates
  • Pemetrexed
  • Guanine
  • Carboplatin
  • Cetuximab